BioXcel Therapeutics Announces Completion of Patient Enrollment in Safety Portion of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with KEYTRUDA®

Press/Media

Period	6 Feb 2024

Media coverage

Title	BioXcel Therapeutics Announces Completion of Patient Enrollment in Safety Portion of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with KEYTRUDA®
Media name/outlet	BioSpace
Country/Territory	United States
Date	6/02/24
URL	https://www.biospace.com/article/releases/bioxcel-therapeutics-announces-completion-of-patient-enrollment-in-safety-portion-of-investigator-sponsored-phase-2-relapsed-pancreatic-cancer-trial-of-bxcl701-in-combination-with-keytruda-/
Persons	Suresh Agarwal